Brief: Xeris Biopharma Reports Third Quarter 2022 Financial Results And Recent Events

Xeris Biopharma Holdings

09/11/2022 12:20

Nov 9 (Reuters) - Xeris Biopharma Holdings Inc  XERS.O :
    * XERIS BIOPHARMA REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND
RECENT EVENTS
    * CO ENDED Q3 WITH $93.4M IN CASH, CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS
    * RAISES 2022 YEAR-END CASH BALANCE GUIDANCE FROM $90
MILLION
-$110 MILLION TO $110 MILLION-$120M MILLION
    * REMAINS ON TRACK TO ACHIEVE $50M IN SYNERGIES BY YEAR-END
2022
AND CASH FLOW BREAKEVEN BY YEAR-END 2023
    * QTRLY LOSS PER SHARE $0.16
    * Q3 EARNINGS PER SHARE VIEW $-0.17 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw63BsNKa 
Further company coverage:  XERS.O 
 ((Reuters.Briefs@thomsonreuters.com))